ADVIL DUAL ACTION WITH ACETAMINOPHEN

Product NDC: 67751-211
Requested package NDC: 67751-211-01
11-digit product format: 677510211
Labeler code: 67751
Product ID: 67751-211_16264d4c-f111-10c1-e063-6294a90a9beb
Type: HUMAN OTC DRUG
Nonproprietary name: Ibuprofen, Acetaminophen
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Navajo Manufacturing Company Inc.
Application: NDA211733
Marketing category: NDA
Marketing start: 2021-05-21
Substance: IBUPROFEN; ACETAMINOPHEN
Active strength: 125; 250 mg/1; mg/1
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 1 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Archive	Snapshot	Source SHA-256
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	67751-211	67751-211-01	I	Inactivated by FDA		excluded / ndc_excluded.zip	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	ACETAMINOPHEN; IBUPROFEN	250MG;125MG	TABLET / ORAL		RLD, RS	2020-02-28

Orange Book patents#

Current patent rows page 1 of 1 · 1 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N211733-001	11918693	2041-07-09		Drug product	2024-03-26

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`c0c555d07b60…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N211733-001	ADVIL DUAL ACTION WITH ACETAMINOPHEN	250MG;125MG	TABLET / ORAL	RLD, RS	2020-02-28	`a50c72e98297…`

Observed Orange Book patent history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N211733-001	11918693	2041-07-09	Drug product	2024-03-26	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N211733-001	11918693	2041-07-09	Drug product	2024-03-26	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N211733-001	11918693	2041-07-09	Drug product	2024-03-26	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N211733-001	11918693	2041-07-09	Drug product	2024-03-26	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N211733-001	11918693	2041-07-09	Drug product	2024-03-26	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N211733-001	11918693	2041-07-09	Drug product	2024-03-26	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N211733-001	11918693	2041-07-09	Drug product	2024-03-26	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N211733-001	11918693	2041-07-09	Drug product	2024-03-26	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N211733-001	11918693	2041-07-09	Drug product	2024-03-26	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N211733-001	11918693	2041-07-09	Drug product	2024-03-26	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N211733-001	11918693	2041-07-09	Drug product	2024-03-26	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N211733-001	11918693	2041-07-09	Drug product	2024-03-26	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N211733-001	11918693	2041-07-09	Drug product	2024-03-26	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N211733-001	11918693	2041-07-09	Drug product	2024-03-26	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N211733-001	11918693	2041-07-09	Drug product	2024-03-26	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N211733-001	11918693	2041-07-09	Drug product	2024-03-26	`8072bd15b7f6…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N211733-001	11918693	2041-07-09	Drug product	2024-03-26	`a50c72e98297…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N211733-001	NP	2023-02-28	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N211733-001	NP	2023-02-28	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N211733-001	NP	2023-02-28	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	N211733-001	NP	2023-02-28	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N211733-001	NP	2023-02-28	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N211733-001	NP	2023-02-28	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N211733-001	NP	2023-02-28	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N211733-001	NP	2023-02-28	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N211733-001	NP	2023-02-28	`c0c555d07b60…`
2023-12-20 04:57 UTC	2023-12	N211733-001	NP	2023-02-28	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N211733-001	NP	2023-02-28	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N211733-001	NP	2023-02-28	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N211733-001	NP	2023-02-28	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N211733-001	NP	2023-02-28	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N211733-001	NP	2023-02-28	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N211733-001	NP	2023-02-28	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N211733-001	NP	2023-02-28	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N211733-001	NP	2023-02-28	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N211733-001	NP	2023-02-28	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N211733-001	NP	2023-02-28	`cb3db0bc1861…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: ADVIL DUAL ACTION WITH ACETAMINOPHEN
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
IBUPROFEN	125 mg/1
ACETAMINOPHEN	250 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
WK2XYI10QM	Internal UNII lookup
362O9ITL9D	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
2387532	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
bd0d7812-4e42-b533-e053-2995a90ae1f9	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
1e73f975-1ce7-705e-2bcf-788b1b5e24ba	Product name	5	20251124
16cde546-8deb-4df2-a072-dab5566ede95	Product name	1	20231003
f6d1b8d7-3bd1-4248-eddd-b60565c88015	Product name	4	20230808
874f4e63-49d2-5150-5d77-052172814ebd	Product name	6	20230105
557673c2-8256-b351-e863-4ec71a5a64b0	Product name	2	20160714
dbc9a339-6215-4e94-9546-57a3b34902ce	Product name	1	20160517
61c18d4e-b552-5478-8fc0-df38b93e3100	Product name	1	20140508
7b2938c9-7eb7-e312-ae90-f54f4240361e	Product name	1	20140508
997601aa-bb5f-6971-6b90-a21132c12c7b	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
67751-211-01	2024-04-15	Advil Dual Action with Acetaminophen
67751-211-02	2024-04-15	Advil Dual Action with Acetaminophen
67751-211-01	2024-01-30	Advil Dual Action with Acetaminophen
67751-211-02	2024-01-30	Advil Dual Action with Acetaminophen

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
67751-211-01	ADVIL DUAL ACTION WITH ACETAMINOPHEN	1 in 1 CARTON	TABLET, FILM COATED	1	3
67751-211-01	ADVIL DUAL ACTION WITH ACETAMINOPHEN	2 in 1 POUCH	TABLET, FILM COATED	2	3
67751-211-02	ADVIL DUAL ACTION WITH ACETAMINOPHEN	2 in 1 POUCH	TABLET, FILM COATED	2	3
67751-211-02	ADVIL DUAL ACTION WITH ACETAMINOPHEN	2 in 1 CARTON	TABLET, FILM COATED	2	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
67751-211	ADVIL DUAL ACTION WITH ACETAMINOPHEN (IBUPROFEN, ACETAMINOPHEN) TABLET, FILM COATED [NAVAJO MANUFACTURING COMPANY INC.]	3	Current NDC, Legacy NDC, 4 package rows	20240417_bd0d7812-4e42-b533-e053-2995a90ae1f9.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ADVIL DUAL ACTION WITH ACETAMINOPHEN	IBUPROFEN, ACETAMINOPHEN	Select Consumer Group	55cd65fc-91bf-4979-e063-6294a90ab9b7	2026-07-04	Warnings	Exact identifier application applno (NDA): 211733 application number: NDA211733
Advil Dual Action with Acetaminophen, Travel BASIX	IBUPROFEN, ACETAMINOPHEN TABLET, FILM COATED	Lil' Drug Store Products, Inc.	030d9bca-a934-6ef9-e063-6394a90a8277	2025-12-01	Warnings	Exact identifier application applno (NDA): 211733 application number: NDA211733
ADVIL DUAL ACTION WITH ACETAMINOPHEN	IBUPROFEN, ACETAMINOPHEN	Haleon US Holdings LLC	f5ea858e-76d9-4777-b3dc-5d614f66d485	2025-04-21	Warnings	Exact identifier application applno (NDA): 211733 application number: NDA211733
ADVIL DUAL ACTION WITH ACETAMINOPHEN Back Pain	IBUPROFEN, ACETAMINOPHEN	Haleon US Holdings LLC	acaa9806-e552-44f2-a680-b8bb64c49e1f	2024-04-24	Warnings	Exact identifier application applno (NDA): 211733 application number: NDA211733
ADVIL DUAL ACTION WITH ACETAMINOPHEN	IBUPROFEN, ACETAMINOPHEN	Navajo Manufacturing Company Inc.	bd0d7812-4e42-b533-e053-2995a90ae1f9	2024-04-15	Warnings	Exact identifier application applno (NDA): 211733 application number: NDA211733 ndc (package): 67751-211-01 ndc (product): 67751-211 ndc11 (package): 67751021101

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
WK2XYI10QM	IBUPROFEN	15687-27-1	IBUPROFEN
362O9ITL9D	ACETAMINOPHEN	103-90-2	ACETAMINOPHEN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
2387532	acetaminophen 250 MG / ibuprofen 125 MG Oral Tablet	PSN	bd0d7812-4e42-b533-e053-2995a90ae1f9	3
2387532	acetaminophen 250 MG / ibuprofen 125 MG Oral Tablet	SCD	bd0d7812-4e42-b533-e053-2995a90ae1f9	3
2387532	APAP 250 MG / ibuprofen 125 MG Oral Tablet	SY	bd0d7812-4e42-b533-e053-2995a90ae1f9	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
67751-211-01	67751021101	1 POUCH in 1 CARTON (67751-211-01) / 2 TABLET, FILM COATED in 1 POUCH	1 pouch	2021-05-21	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Advil Dual Action with Acetaminophen	Navajo Manufacturing Company Inc.	2024-04-15	HUMAN OTC DRUG LABEL	3